Geron Other Current Liab from 2010 to 2024

GERN Stock  USD 4.07  0.05  1.24%   
Geron Other Current Liabilities yearly trend continues to be very stable with very little volatility. Other Current Liabilities is likely to grow to about 56.8 M this year. During the period from 2010 to 2024, Geron Other Current Liabilities quarterly data regression pattern had sample variance of 376.8 T and median of  10,464,000. View All Fundamentals
 
Other Current Liabilities  
First Reported
1996-03-31
Previous Quarter
50 M
Current Value
123.2 M
Quarterly Volatility
18.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Geron financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Geron's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 8.7 M or Selling General Administrative of 72.6 M, as well as many indicators such as Price To Sales Ratio of 5.3 K, Dividend Yield of 0.0 or PTB Ratio of 2.86. Geron financial statements analysis is a perfect complement when working with Geron Valuation or Volatility modules.
  
Check out the analysis of Geron Correlation against competitors.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.

Latest Geron's Other Current Liab Growth Pattern

Below is the plot of the Other Current Liab of Geron over the last few years. It is Geron's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Geron's overall financial position and show how it may be relating to other accounts over time.
Other Current Liab10 Years Trend
Slightly volatile
   Other Current Liab   
       Timeline  

Geron Other Current Liab Regression Statistics

Arithmetic Mean19,805,623
Geometric Mean8,602,154
Coefficient Of Variation98.01
Mean Deviation16,341,548
Median10,464,000
Standard Deviation19,411,673
Sample Variance376.8T
Range56.8M
R-Value0.86
Mean Square Error104.8T
R-Squared0.74
Significance0.000037
Slope3,738,327
Total Sum of Squares5275.4T

Geron Other Current Liab History

202456.8 M
202354.1 M
202244.6 M
202137 M
202022.3 M
201926.6 M
20186.6 M

About Geron Financial Statements

Geron investors utilize fundamental indicators, such as Other Current Liab, to predict how Geron Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Other Current Liabilities54.1 M56.8 M
When determining whether Geron offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Geron's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Geron Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Geron Stock:
Check out the analysis of Geron Correlation against competitors.
To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.32)
Revenue Per Share
0.047
Quarterly Revenue Growth
171.384
Return On Assets
(0.30)
Return On Equity
(0.69)
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.